Drugs / Potassium Supplement
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06467825 Background | Aug 2022 → Sep 2025 overdue | — | National Aeronautics and Space Administration (NASA) | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Potassium Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06467825 ↗ |
| Route | Oral | “An oral potassium supplement of 20 mEq (Milliequivalent) will be given as a prophylactic prior to the furosemide infusion.” NCT06467825 ↗ |